Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
gene therapy
gilead sciences
4
×
glaxosmithkline
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
4
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
biotech
cancer immunotherapy
clinical trials
immunotherapy
novartis
alzheimer's disease
biogen
crispr
cystic fibrosis
deals
What
bio
roundup
crispr
drug
new
pharma
abbvie’s
acquisitions
ahead
albert
approval
biggest
biofourmis
biogen’s
biopharma
biopharmaceutical
bourla
bucks
cancer
celebrate
ceo
chance
companies
company
congress
congressional
convo
corner
day
days
earlier
executives
failures
feud
forward
future
group
holiday
imports
isn’t
Language
unknown
unset
Current search:
glaxosmithkline
×
" seattle blog main "
×
" gilead sciences "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More